文献速递主动脉疾病

倾向性评分匹配比较两种髂分支装置在相似术前特征患者中的效果

A propensity score-matched comparison of two commercially available iliac branch devices in patients with similar clinical and anatomic preoperative features.
PubMed 文献 · J Vasc Surg · 2019-09-03

本研究通过倾向性评分匹配,比较了Cook ZBIS与Gore IBE两种髂分支装置在治疗髂动脉分叉扩张患者中的围手术期和中远期结果。匹配后每组各35例,技术成功率均为100%,围手术期无死亡,随访期间无分支闭塞,36个月免于I/III型内漏、再干预及动脉瘤相关死亡两组间无显著差异。

要点

  • 两种髂分支装置在匹配后患者中技术成功率均达100%,围手术期无死亡。
  • 随访期间两组均无髂分支或靶向臀下动脉闭塞。
  • 36个月免于I/III型内漏、再干预及动脉瘤相关死亡两组间无显著差异。

核心结论

  • Cook ZBIS与Gore IBE装置在倾向性评分匹配后显示出相似且满意的围手术期和中远期结果。

研究设计与样本

  • 回顾性倾向性评分匹配研究,纳入2007年7月至2018年5月两家意大利高容量血管中心植入的190个髂分支装置。
  • 匹配后形成两组:组1为35例Cook ZBIS植入,组2为35例Gore IBE装置。

主要发现

  • 两组技术成功率均为100%,组1有1例围手术期髂分支装置相关并发症及主要并发症(P = .49)。
  • 两组均无围手术期死亡,随访期间无髂分支装置或靶向臀下动脉闭塞。
  • 估计36个月免于I型和III型内漏率组1为97%(SE 0.03),组2为87%(SE 0.09)(P = .34)。
  • 估计免于髂分支装置相关再干预率组1为97%(SE 0.03),组2为93%(SE 0.06)(P = .81)。
  • 估计36个月总生存率组1为95%(SE 0.04),组2为88%(SE 0.08)(P = .03);免于动脉瘤相关死亡率组1为100%,组2为93%(SE 0.06)(P = .19)。

临床怎么用

  • 在相似术前解剖和临床特征的患者中,两种髂分支装置均可获得满意的围手术期和中远期结果。

局限性

  • 组1平均随访46.7个月(标准差±36.3),组2平均随访20.8个月(标准差±15.9),两组随访时间存在显著差异(P < .0001)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to compare the perioperative and midterm results of Zenith Bifurcated Iliac Side (ZBIS; Cook Medical, Bloomington, Ind) and Gore Iliac Branch Endoprosthesis (IBE; W. L. Gore & Associates, Flagstaff, Ariz) iliac branch devices (IBDs) in treatment of dilated iliac bifurcations in patients with similar anatomic and clinical preoperative features. METHODS: Between July 2007 and May 2018, 190 IBDs were implanted at two high-volume Italian vascular and endovascular centers. Among the series, preoperative propensity score matching based on preoperative anatomic and clinical factors was performed, and two homogeneous groups were created: group 1, 35 Cook ZBIS IBD implants; and group 2, 35 Gore IBE devices. Early results were analyzed in terms of technical success, death, conversion to open surgery, and occurrence of major local and systemic complications. Follow-up results were analyzed in terms of patency of the IBD, freedom from type I and type III endoleaks, aneurysm-related reintervention, and aneurysm-related death. RESULTS: Technical success was achieved in all implants from both groups. Perioperative IBD-related complications and major complications occurred in one case from group 1 (P = .49). No perioperative mortality was recorded in the two groups. Mean postoperative follow-up was 46.7 months in group 1 (standard deviation, ± 36.3) and 20.8 months in group 2 (standard deviation, ± 15.9; P < .0001). None of the IBDs or target hypogastric arteries occluded during follow-up in this series. Estimated 36-month freedom from type I and type III endoleaks was 97% (standard error [SE], 0.03) in group 1 and 87% (SE, 0.09) in group 2 (P = .34; log-rank, 0.9). Estimated freedom from IBD-related reintervention was 97% (SE, 0.03) in group 1 and 93% (SE, 0.06) in group 2 (P = .81; log-rank, 0.05). The estimated rates of overall survival at 36 months from the IBD implantation were 95% (SE, 0.04) in group 1 and 88% (SE, 0.08) in group 2 (P = .03; log-rank, 4.7); freedom from aneurysm-related death was 100% in group 1 and 93% (SE, 0.06) in group 2 (P = .19; log-rank, 1.7). CONCLUSIONS: The propensity score-matched comparison between the Cook ZBIS and Gore IBE devices showed similar, satisfying perioperative and midterm results in the experience of two high-volume Italian vascular centers.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Masciello F, Fargion AT, Pratesi G, et al. A propensity score-matched comparison of two commercially available iliac branch devices in patients with similar clinical and anatomic preoperative features. J Vasc Surg. 2019. PMID: 31492612. doi:10.1016/j.jvs.2019.07.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。